Lenvatinib Capsules

Lenvatinib Capsules

Categories : Oncology

Product Packaging : 30 in HDPE

Product Composition : 4mg, 10mg

Lenvatinib Capsules are an advanced oral multi-kinase inhibitor used in the treatment of various cancers, particularly thyroid cancer, hepatocellular carcinoma (liver cancer), and renal cell carcinoma. It works by inhibiting multiple receptor tyrosine kinases (RTKs) involved in tumor growth and angiogenesis, thereby slowing cancer progression.

Genliva Wellness LLP is a trusted Lenvatinib capsule exporter from India, offering high-quality targeted oncology capsule formulations for export markets. As a pharma contract manufacturer and third party manufacturing company in India, Genliva supplies oncology medicines to international distributors, hospitals, and pharmaceutical importers with a strong focus on quality, regulatory compliance, and consistency.

Send Message

Lenvatinib Capsules are an advanced oral multi-kinase inhibitor used in the treatment of various cancers, particularly thyroid cancer, hepatocellular carcinoma (liver cancer), and renal cell carcinoma. It works by inhibiting multiple receptor tyrosine kinases (RTKs) involved in tumor growth and angiogenesis, thereby slowing cancer progression.

Genliva Wellness LLP is a trusted Lenvatinib capsule exporter from India, offering high-quality targeted oncology capsule formulations for export markets. As a pharma contract manufacturer and third party manufacturing company in India, Genliva supplies oncology medicines to international distributors, hospitals, and pharmaceutical importers with a strong focus on quality, regulatory compliance, and consistency.

Lenvatinib Capsules are indicated for:

  • Differentiated thyroid cancer (DTC)
  • Hepatocellular carcinoma (liver cancer)
  • Renal cell carcinoma (RCC)
  • Use in targeted oncology treatment regimens

whatsapp-app